Catalyst Wire Dossier Catalyst Wire Dossier

Huperzine

Huperzine A · Biomedisyn Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Huperzine, covering 2013-03-01 to 2013-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Huperzine for Cognitive and Functional Impairment in Schizophrenia [Phase 2]

See pricing